Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT)’s Cullinan Oncology CGEM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.28M	Sell	90,316 -28,976	-24%	-$372K	﹤0.01%	2384
2025 Q4	$1.23M	Sell	119,292 -33,117	-22%	-$299K	﹤0.01%	2467
2025 Q3	$904K	Buy	152,409 +85,290	+127%	+$625K	﹤0.01%	2564
2025 Q2	$505K	Buy	+67,119	New	+$539K	﹤0.01%	2689
2025 Q1	–	Sell	-13,609	Closed	-$166K	–	3544
2024 Q4	$166K	Buy	+13,609	New	+$196K	﹤0.01%	2881
2024 Q3	–	Sell	-190,520	Closed	-$3.32M	–	3400
2024 Q2	$3.32M	Buy	190,520 +75,408	+66%	+$1.61M	0.01%	1443
2024 Q1	$1.96M	Buy	115,112 +108,266	+1,581%	+$1.67M	﹤0.01%	1773
2023 Q4	$69.8K	Buy	+6,846	New	+$60.6K	﹤0.01%	3213
2022 Q2	–	Sell	-16,628	Closed	-$174K	–	2555
2022 Q1	$174K	Sell	16,628 -13,524	-45%	-$183K	﹤0.01%	1978
2021 Q4	$465K	Buy	+30,152	New	+$601K	﹤0.01%	1607

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return